ICMR, Biological E develop potential treatment for COVID-19
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The Indian Council of Medical Research (ICMR) on 1 October said it has developed highly purified 'antisera' for prevention and treatment of the novel coronavirus pandemic.

"ICMR and Biological E. Limited, Hyderabad have developed highly purified antisera (raised in animals) for prophylaxis and treatment of COVID-19," read a statement from the ICMR.

"The 'antisera' is yet to undergo human clinical trials to establish its safety and efficacy and Drugs Controller General of India would be approached soon in this regard", ICMR said.

Antisera are blood serum high in antibodies against specific antigens and are injected in humans to help kickstart the immune system to fight specific infections.

"Although, plasma recovered from patients experiencing COVID - 19 could serve a similar purpose, the profile of antibodies, their efficacy and concentration keep varying from one patient to another and therefore make it an unreliable clinical tool for patient management," the ICMR said.

Further, the ICMR added, "Standardization achievable through equine sera based treatment modality thus stands out as yet another remarkable public health initiative supported by ICMR in the time of COVID 19."

Source: https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/icmr-biological-e-ltd-develop-potential-treatment-for-covid-19/articleshow/78440108.cms
Dr. T●●●●z H●●●●●●i and 6 others like this3 shares
Like
Comment
Share